eDrugstore.com launches a landmark Black Friday promotion through Groupon, offering near-total savings on pivotal men’s health treatments. Groupon’s strategic expansion into high-value verticals like telehealth signals a aggressive turnaround phase for the company. Analysts now champion Groupon’s stock as a top pick, citing a dramatic financial recovery and a clear path to sustainable revenue growth.
In a strategic move to capture holiday spending, the telehealth leader eDrugstore has partnered with the reemergent deals platform Groupon for a major Black Friday and Cyber Monday event. The promotion features discounts of up to 95% on FDA-approved men’s health products and virtual care services. This includes premier erectile dysfunction medications like sildenafil and tadalafil, as well as personalized compound formulas, making effective treatments more accessible and affordable through a discreet, digital platform.
Further deepening the value, the promotion extends to clinically validated hair loss therapies. Customers can access significant savings on combination treatments featuring minoxidil and finasteride, which are proven to combat thinning hair. This partnership allows individuals to conveniently obtain personalized care plans and prescription treatments entirely through eDrugstore’s secure online portal. For Groupon, this high-impact collaboration marks a deliberate expansion beyond its core “Things To Do” and beauty categories into the high-growth telehealth and wellness sector.
This deal is a cornerstone of Groupon’s ambitious plan to rebuild its marketplace relevance. Under the operational model of its revitalized Chicago headquarters, which has more than doubled its workforce, the company is aggressively recruiting local and national merchants. Spearheaded by CFO Dushyanth “Kashyap” Kashyap, the focus has shifted from austerity to revenue growth, using major partnerships like eDrugstore’s to attract a renewed customer base. The Chicago office now buzzes with activity as retrained sales teams work to onboard a diverse array of new offers.
This operational resurgence coincides with a dramatic financial turnaround that has captured Wall Street’s attention. Investment firm Northland Capital recently named Groupon its 2026 Top Pick, highlighting an “unappreciated” return to growth and a solidified balance sheet. With a price target of $42 and an Outperform rating, analysts point to consecutive quarters of exceeding expectations. Once considered a cautionary tale, Groupon has resolved its going-concern issues and is now posting forecasts of significant year-over-year earnings per share growth, signaling a potent new chapter for the pioneer of digital deals.
